Condition
Haemophagocytic Lymphohistiocytosis clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Haemophagocytic Lymphohistiocytosis clinical trials that are recruiting, at sites in 2 countries (most in United Kingdom (1), France (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Ruxolitinib as first-line treatment for primary haemophagocytic lymphohistiocytosis
This will test whether ruxolitinib plus corticosteroids helps children and young adults with primary HLH survive until they can receive a stem cell transplant.
-
Detecting cancer DNA in patients with severe blood disease
This study is testing if a blood test for cancer DNA can help doctors find lymphoma earlier in patients with a severe blood disease called HLH.
Related topics
Quick answers
How many Haemophagocytic Lymphohistiocytosis clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United Kingdom (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.